para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase in Mycobacterium tuberculosis
Open Access
- 9 August 2013
- journal article
- Published by Elsevier BV
- Vol. 288 (32), 23447-23456
- https://doi.org/10.1074/jbc.m113.475798
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene ExpressionPLoS Pathogens, 2011
- Depletion of antibiotic targets has widely varying effects on growthProceedings of the National Academy of Sciences of the United States of America, 2011
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyNature Communications, 2010
- Mycobacterium tuberculosis and Sulfamethoxazole SusceptibilityAntimicrobial Agents and Chemotherapy, 2010
- Tuberculosis and Trimethoprim-SulfamethoxazoleAntimicrobial Agents and Chemotherapy, 2009
- Molecular Genetics of para -Aminosalicylic Acid Resistance in Clinical Isolates and Spontaneous Mutants of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2009
- Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 ofMycobacterium tuberculosisFEMS Microbiology Letters, 2008
- Structures ofMycobacterium tuberculosisfolylpolyglutamate synthase complexed with ADP and AMPPCPActa Crystallographica Section D-Structural Biology, 2008
- Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant TuberculosisScience, 2002
- Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugsJournal of Molecular Biology, 2000